Cue biopharma to present at the piper sandler 33rd annual healthcare conference

Cambridge, mass., nov. 22, 2021 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells within the patient's body, announced today that it participated in a pre-recorded fireside chat as part of the piper sandler 33rd annual virtual healthcare conference, being held on november 29-december 2, 2021.
CUE Ratings Summary
CUE Quant Ranking